2017
DOI: 10.3390/md15050126
|View full text |Cite
|
Sign up to set email alerts
|

A Review Study on Macrolides Isolated from Cyanobacteria

Abstract: Cyanobacteria are rich sources of structurally-diverse molecules with promising pharmacological activities. Marine cyanobacteria have been proven to be true producers of some significant bioactive metabolites from marine invertebrates. Macrolides are a class of bioactive compounds isolated from marine organisms, including marine microorganisms in particular. The structural characteristics of macrolides from cyanobacteria mainly manifest in the diversity of carbon skeletons, complexes of chlorinated thiazole-co… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
26
0
1

Year Published

2018
2018
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 38 publications
(27 citation statements)
references
References 59 publications
0
26
0
1
Order By: Relevance
“…These unique organisms produce as secondary metabolites a number of biologically active substances with antifungal, antibacterial, antitumor, immunosuppressive, immunostimulating and toxic effects [7][8][9]. This determined their high potential as sources of substances used in the food and pharmaceutical industries, medicine and biotechnology.…”
mentioning
confidence: 99%
“…These unique organisms produce as secondary metabolites a number of biologically active substances with antifungal, antibacterial, antitumor, immunosuppressive, immunostimulating and toxic effects [7][8][9]. This determined their high potential as sources of substances used in the food and pharmaceutical industries, medicine and biotechnology.…”
mentioning
confidence: 99%
“…Marine cyanobacteria are extraordinarily rich in biologically active and structurally diverse natural products (NPs), often times deriving from hybrid nonribosomal peptide synthetase (NRPS) and polyketide synthase (PKS) biosynthetic pathways [1][2][3]. However, those cyanobacterial NPs with an exclusive PKS origin are often cyclized to form macrolides, a class of compounds that generally possesses important biomedical properties [4,5]. From other microbial sources, macrolide NPs have proven utility in treating human diseases, such as erythromycin and clarithromycin, as antibiotics, tacrolimus as a macrolide immunosuppressant, and amphotericin B and nystatin as antifungals.…”
Section: Introductionmentioning
confidence: 99%
“…Two main aspects, the chemical diversity and the related bioactivity, have to be considered when considering the application potential of natural products (molecules, metabolites, or compounds) produced by cyanobacteria. The chemical diversity of metabolites produced by cyanobacteria has been largely described and about fifteen reviews have been already published in the past twenty years dealing with their structural and chemical diversity [9][10][11][12][13][14] or their corresponding biosynthetic pathways [15,16]. Beyond the notorious harmful effects of cyanotoxins, other cyanobacterial natural products show a wide range of bioactivities that could be potentially useful for diverse application fields [17][18][19][20][21].…”
Section: Introductionmentioning
confidence: 99%